Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Juliana Liu - Indian Pharma Has Little Reason to Fear Trump
Indian Pharma Has Little Reason to Fear Trump
Bloomberg

Indian pharmaceutical firms have spent decades supplying American patients with affordable medicines. That dominance will be difficult to challenge, despite President Donald Trump's threat to impose steep tariffs on imported generic drugs. His…

indianexpress.com - Education Desk - IIM Ahmedabad launches digital archive documenting 125 years of Indian pharma history
IIM Ahmedabad launches digital archive documenting 125 years of Indian pharma history
The Indian Express

2 min read New Delhi Make us preferred source on Google The Indian Institute of Management Ahmedabad (IIMA) on Saturday unveiled India Pharma Archives, a digital platform that takes viewers through the 125-year-long history of Indian pharma. The…

fool.com - Jonathan Ponciano - Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened
The Motley Fool

Deborah Weitzman, CEO of the PSS Segment, reported a sale of 7,354 shares of Cardinal Health, Inc. (CAH +0.46%) in a recent SEC Form 4 filing. MetricValueTransaction value~$1.7 millionShares sold7,354Post-transaction shares (directly…

thehindubusinessline.com - 20 stocks in focus on Monday: Lenskart, Natco Pharma, Power Grid, GHCL, Sigachi and others
20 stocks in focus on Monday: Lenskart, Natco Pharma, Power Grid, GHCL, Sigachi and others
BusinessLine

According to market buzz, Softbank Vision Fund (SVF) II Lightbulb Cayman plans to sell up to a 2.6% stake in Lenskart Solutions, with a floor price of ₹635 per share. Jubilant Pharmova Ltd has informed the exchanges that the US drug…

thehindubusinessline.com - Sun Pharma's recall of eyedrops: Experts raise concerns on implementation and enforcement
Sun Pharma's recall of eyedrops: Experts raise concerns on implementation and enforcement
BusinessLine

The recent voluntary withdrawal of Sun Pharmaceutical's eye drops has raised concerns on the implementation and enforcement of recalled products - as some retailers and regulatory officials claim they did not have information on the recall. Sun had…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Given Average Rating of 'Moderate Buy' by Brokerages
Urogen Pharma (NASDAQ:URGN) Given Average Rating of 'Moderate Buy' by Brokerages
MarketBeat

Shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) have been assigned a consensus rating of 'Moderate Buy' from the ten analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell…

erictopol.substack.com - Eric Topol - Deborah Cohen: The Wellness-Industrial Complex
Deborah Cohen: The Wellness-Industrial Complex
Ground Truths

A transcript unlocks clips, previews, and editing. The Sick Until Proven Healthy Trap Deb Cohen is an award winning investigative journalist and correspondent who trained as a physician and has worked with the BBC and BMJ. She just published BAD…

thehindubusinessline.com - Stock market today: Nifty, Sensex may open weak on global cues
Stock market today: Nifty, Sensex may open weak on global cues
BusinessLine

Indian stocks are likely to open on a weak note on Monday, due to lacklustre signals emanating from global markets. Persistent tensions in West Asia and elevated crude oil prices continue to keep the market volatile. Crude prices remain firm, with…

thehindubusinessline.com - Team BL - Stock Market Today Live: Stock to buy today: IndusInd Bank
Stock Market Today Live: Stock to buy today: IndusInd Bank
BusinessLine

Sensex Today, Nifty 50 | Stock Market Live Updates: Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 24th August 2026. Urban Company said the Delhi High Court has directed Kent RO Systems…

koreatimes.co.kr - Yonhap - Korea's top pharmaceutical firms spend over $72.13 mil. each in first hald of the year for R&D: data
Korea's top pharmaceutical firms spend over $72.13 mil. each in first hald of the year for R&D: data
The Korea Times

Korea's major pharmaceutical companies spent around 100 billion won ($72.13 million) each in the first half for the research and development (R&D) of new drugs, data showed Sunday, in an apparent bid to secure future growth engines. Yuhan Corp.…

fool.com - Keith Speights - Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?
Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?
The Motley Fool

It's easy for a stock to get lost in the crowd when a portfolio has an enormous number of holdings. Citadel Advisors, the hedge fund founded and led by billionaire Ken Griffin, owns nearly 7,500 stocks and thousands of options, according to its…

247wallst.com - Vandita Jadeja - Prediction: Eli Lilly Could Be One of the Biggest Winners of the Next Decade. Here's Why.
Prediction: Eli Lilly Could Be One of the Biggest Winners of the Next Decade. Here's Why.
24/7 Wall St

Eli Lilly (NYSE:LLY | LLY Price Prediction) just posted one of the most impressive quarters in Big Pharma history. Revenue jumped 47.67% to $22.974 billion, Mounjaro alone did $9.943 billion, and management raised full-year guidance again. Shares…

indianexpress.com - Pragynesh - Rs 7,000 crore cocaine haul, Dubai hideout, Delhi network: Story of Virender Baisoya
Rs 7,000 crore cocaine haul, Dubai hideout, Delhi network: Story of Virender Baisoya
The Indian Express

“After the celebrations, he left the country again,” recalls a senior officer with the Special Cell of Delhi Police. It would be the last time Delhi police investigators saw him in the national capital. Eight months later, Baisoya's…

fool.com - Jonathan Ponciano - Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know
Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know
The Motley Fool

Jessica L. Mayer, chief legal officer of Cardinal Health, Inc. (CAH +0.46%), sold 29,436 shares of common stock at $236.19 per share on August 18, according to an SEC Form 4 filing. MetricValueShares sold29,436Transaction value~$7.0…

cyclingweekly.com - Vern Pitt - 'Hopefully it's not the last one' - Matthew Brennan wins his first grand tour stage in debut Vuelta a España
'Hopefully it's not the last one' - Matthew Brennan wins his first grand tour stage in debut Vuelta a España
Cycling Weekly

British sprinter Matthew Brennan won his first ever grand tour stage at his first attempt on the second day of racing at the Vuelta a España. The Visma-Lease a Bike sprinter is riding his first ever grand tour at the Spanish race. Brennan…

Receive a Daily briefing on Pharma Industry News

Get Started